Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05766> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05766 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05766 label "ACP-104 [drugbank:DB05766]" assertion.
- drugbank:DB05766 seeAlso DB05766 assertion.
- drugbank:DB05766 description "ACP-104, or N-desmethylclozapine, is the major metabolite of clozapine, and is being developed by ACADIA as a novel, stand-alone therapy for schizophrenia. It combines an atypical antipsychotic efficacy profile with the added potential benefit of enhanced cognition, thereby addressing one of the major challenges in treating schizophrenia today." assertion.
- drugbank:DB05766 identifier "drugbank:DB05766" assertion.
- drugbank:DB05766 title "ACP-104" assertion.
- drugbank:DB05766 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05766 drugbank_vocabulary:drugbank-id "DB05766" assertion.
- drugbank:DB05766 bio2rdf_vocabulary:x-identifiers.org DB05766 assertion.
- drugbank:DB05766 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05766" assertion.
- drugbank:DB05766 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05766 bio2rdf_vocabulary:identifier "DB05766" assertion.